[Reintervention in C-cell carcinoma]

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Context:

• Medullary thyroid cancer (MTC) management involves addressing persistent disease after initial treatment.
• Serum calcitonin levels are a key biomarker for MTC recurrence and tumor-free status.
• Cervical re-exploration is a potential strategy for persistent or recurrent MTC.

Purpose:

• To evaluate the efficacy of cervical re-exploration in normalizing serum calcitonin levels in patients with persistent medullary thyroid cancer.
• To assess the impact of lymph node status and primary tumor characteristics on treatment outcomes.
• To determine the curability and recurrence control offered by re-exploration, particularly after inadequate primary surgery.

Summary:

• Cervical re-exploration for persistent medullary thyroid cancer infrequently normalizes serum calcitonin (2/21 patients).
• Positive lymph nodes significantly correlate with poorer postoperative calcitonin normalization rates (18%) compared to cases with negative nodes (71-86%).
• Re-exploration may offer a curative option for recurrence control, especially post-inadequate primary surgery, with expected calcitonin reduction in the absence of distant metastases.

Impact:

• Highlights the limited utility of cervical re-exploration solely for calcitonin normalization in persistent MTC.
• Emphasizes the critical prognostic importance of lymph node involvement in medullary thyroid cancer.
• Suggests cautious consideration for reoperation in patients with elevated calcitonin levels as the sole indicator of persistent disease, due to potential for occult distant metastases.